Dora Buonfrate Selected Research

Strongyloidiasis

4/2022	The accuracy of a recombinant antigen immunochromatographic test for the detection of Strongyloides stercoralis infection in migrants from sub-Saharan Africa.
8/2021	Diagnostic accuracy of a novel enzyme-linked immunoassay for the detection of IgG and IgG4 against Strongyloides stercoralis based on the recombinant antigens NIE/SsIR.
6/2021	Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol.
1/2021	Preventive chemotherapy for the control of strongyloidiasis in school-age children: Estimating the ivermectin need.
10/2020	Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis.
7/2020	Strategies for management of strongyloidiasis in migrants from Sub-Saharan Africa recently arrived in Italy: A cost-effectiveness analysis.
6/2020	The Global Prevalence of Strongyloides stercoralis Infection.
2/2020	Ivermectin concentration in breastmilk of a woman with Strongyloides stercoralis and human T-lymphotropic virus-I co-infection.
11/2019	Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial.
1/2018	Is Ivermectin Ineffective for Strongyloidiasis?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dora Buonfrate Research Topics

Disease

21	Infections 04/2022 - 01/2012
13	Strongyloidiasis 04/2022 - 07/2011
10	Malaria 09/2021 - 01/2012
7	COVID-19 02/2022 - 01/2021
5	Filarial Elephantiasis (Lymphatic Filariasis) 01/2021 - 09/2017
4	Eosinophilia 11/2021 - 06/2012
4	Onchocerciasis 01/2021 - 11/2015
3	Fever (Fevers) 09/2021 - 01/2012
3	Splenomegaly 04/2016 - 04/2015
2	Bacterial Infections (Bacterial Infection) 09/2021 - 11/2020
2	Schistosomiasis (Bilharziasis) 03/2021 - 10/2019
2	Falciparum Malaria (Plasmodium falciparum Malaria) 06/2020 - 11/2016
2	Neglected Diseases 02/2020 - 01/2020
2	Loiasis 01/2019 - 11/2018
2	Neoplasms (Cancer) 01/2017 - 01/2013
1	Central Nervous System Diseases (CNS Diseases) 02/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2021
1	Crohn Disease (Crohn's Disease) 10/2021
1	Ulcerative Colitis 10/2021
1	Esophageal and Gastric Varices (Esophageal Varices) 01/2021
1	Pulmonary Hypertension 01/2021
1	Reinfection 01/2021
1	Pain (Aches) 01/2021
1	Persistent Infection 10/2020
1	Coinfection 02/2020
1	Scabies (Sarcoptic Mange) 01/2020
1	Schistosomiasis haematobia (Schistosomiasis haematobium) 06/2019
1	Sudden Infant Death (SID) 02/2019
1	Growth Disorders 01/2019
1	Giardiasis 12/2018
1	Virus Diseases (Viral Diseases) 01/2018
1	HIV Infections (HIV Infection) 01/2018
1	Latent Tuberculosis 01/2018
1	Arthritis (Polyarthritis) 09/2017
1	Joint Diseases (Joint Disease) 09/2017
1	Communicable Diseases (Infectious Diseases) 09/2017
1	Anemia 11/2016

Drug/Important Bio-Agent (IBA)

16	Ivermectin (Mectizan)FDA Link 02/2022 - 07/2011
5	Antimalarials (Antimalarial Agents)IBA 06/2020 - 01/2012
4	AntibodiesIBA 12/2021 - 04/2015
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2012
4	Praziquantel (Biltricide)FDA Link 01/2021 - 06/2019
3	AntigensIBA 04/2022 - 03/2021
3	AgarIBA 08/2021 - 08/2016
3	Pharmaceutical PreparationsIBA 02/2020 - 11/2018
3	AnthelminticsIBA 01/2020 - 10/2018
3	Immunoglobulin M (IgM)IBA 04/2016 - 04/2015
2	EnzymesIBA 04/2022 - 08/2021
2	ImmunosorbentsIBA 04/2022 - 08/2021
2	BNT162 VaccineIBA 12/2021 - 01/2021
2	COVID-19 VaccinesIBA 12/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 12/2021 - 01/2021
2	VaccinesIBA 12/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 08/2021 - 04/2016
2	TabletsIBA 01/2020 - 01/2014
2	Albendazole (Albenza)FDA Link 01/2019 - 01/2016
2	Thiabendazole (Mintezol)FDA Link 01/2016 - 07/2011
2	Mefloquine (Lariam)FDA LinkGeneric 01/2014 - 12/2013
1	Antiviral Agents (Antivirals)IBA 02/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2022
1	chloroquine diphosphate FDA LinkGeneric 02/2022
1	Warfarin (Coumadin)FDA LinkGeneric 02/2022
1	Complement System Proteins (Complement)IBA 11/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021
1	Immunoglobulins (Immunoglobulin)IBA 08/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	C-Reactive ProteinIBA 11/2020
1	ChemokinesIBA 10/2020
1	Immunologic Factors (Immunomodulators)IBA 10/2020
1	Interleukin-8 (Interleukin 8)IBA 10/2020
1	benzimidazoleIBA 01/2020
1	ORALIT (ORS)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2018
1	Immunoglobulin E (IgE)IBA 06/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 01/2018
1	Tuberculin (PPD)IBA 01/2018
1	GoldIBA 01/2018
1	Biological ProductsIBA 09/2017
1	artemisinin (artemisinine)IBA 11/2016
1	piperaquineIBA 11/2016
1	artenimol (dihydroartemisinin)IBA 11/2016
1	Hemoglobins (Hemoglobin)IBA 11/2016

Therapy/Procedure

4	Mass Drug Administration 06/2020 - 11/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2017
2	Aftercare (After-Treatment) 11/2021 - 01/2021
2	Biological Therapy 10/2021 - 09/2017
2	Chemoprevention 01/2014 - 12/2013
1	Critical Care (Surgical Intensive Care) 01/2021
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2021
1	Operative Surgical Procedures 01/2021
1	Bathroom Equipment 01/2019
1	Immunotherapy 01/2017
1	Highly Active Antiretroviral Therapy (HAART) 01/2017
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2017
1	Image-Guided Radiotherapy 01/2017
1	Molecular Targeted Therapy 01/2017
1	Radiotherapy 01/2017
1	Therapeutics 11/2016